Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Calponin 2 harnesses metabolic reprogramming to determine kidney fibrosis

Molecular Metabolism(2023)10.1016/j.molmet.2023.101712Source: DataRank Database

Calponin 2 harnesses metabolic reprogramming to determine kidney fibrosis is a research paper published in Molecular Metabolism (2023). On theSindex it has a DataRank of 0. It has been cited 17 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access17 citations

Download PDF

Cite:

Linked data & code

gen doi

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (13 grants)Impact (FWCI 4.10)OA: goldTopics (44)Linked Datasets (10)DataCite Reuse (10)IDs (PubMed, PMC, OpenAlex)Annotations (2)SDGs (1)

FAIR Checklist

Context only (not used in score)

Findable (2/2)

Has DOI
Indexed in repositories

Accessible (1/2)

Open Access

Interoperable (2/2)

DataCite relations
Linked datasets

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (15)

Yuanyuan Wang ORCID,Zachary Palanza ORCID,Jack L. Wang,Priya Gupta ORCID,Jianling Tao

Live enrichment

PubMed:36963615 PMC:PMC10090436 OpenAlex:https://openalex.org/W4353047032

NIDDK

Grant: DK116816

NIDDK

Grant: DK128529

NIDDK

Grant: DK132059

NIDDK NIH HHS

Grant: P30 DK079307

NIDDK NIH HHS

Grant: R03 DK128529

NIDDK NIH HHS

Grant: R01 DK132059

NIDDK NIH HHS

Grant: K01 DK116816

National Institutes of Health

Grant: 5R01DK132059-03

Importance of cell-matrix interactions in kidney repair after acute kidney injury

National Institutes of Health

Grant: 3K01DK116816-03S1

Early and Transient Activation of Fibroblast Promotes Tubule Repair after Acute Kidney Injury.

University of Connecticut

National Institutes of Health

School of Medicine

Washington University in St. Louis

FWCI

4.10

Citation Percentile

1.0%

Citation Trend

2023

2024

2025

2026

goldLicense: cc-by-nc-nd

journalhttps://doi.org/10.1016/j.molmet.2023.101712

publisherhttps://doi.org/10.1016/j.molmet.2023.101712

publisherhttps://api.elsevier.com/content/article/PII:S2212877823000467?httpAccept=text/xml

publisherhttps://api.elsevier.com/content/article/PII:S2212877823000467?httpAccept=text/plain

repositoryhttps://pubmed.ncbi.nlm.nih.gov/36963615

Fields of Study

Chronic Kidney Disease and DiabetesChemotherapy-induced organ toxicity mitigationKidney Stones and Urolithiasis TreatmentsAnimalsMiceFibrosisKidneyKidney DiseasesPPAR alphaCalmodulin-Binding ProteinsCalponinsMicrofilament Proteins

MeSH Terms

CalponinsAnimalsCalmodulin-Binding ProteinsFibrosisKidneyKidney DiseasesMicrofilament ProteinsPPAR alphaMice

Keywords

ReprogrammingMedicineKidneyBioinformaticsEndocrinologyInternal medicineBiologyGeneticsCellProteomicsChronic Kidney DiseaseFatty Acid OxidationEsr2Calponin 2Microfilament ProteinsRC31-1245FibrosisMiceAnimalsKidney DiseasesPPAR alphaCalmodulin-Binding ProteinsCalponins

Sustainable Development Goals

SDG 3: 3. Good health

Additional file 2 of SGLT2 inhibition, high-density lipoprotein, and kidney function: a mendelian randomization study

10.6084/m9.figshare.25449172.v1figshare

Additional file 3 of SGLT2 inhibition, high-density lipoprotein, and kidney function: a mendelian randomization study

10.6084/m9.figshare.26695857.v1figshare

Additional file 5 of SGLT2 inhibition, high-density lipoprotein, and kidney function: a mendelian randomization study

10.6084/m9.figshare.26695863.v1figshare

Additional file 4 of SGLT2 inhibition, high-density lipoprotein, and kidney function: a mendelian randomization study

10.6084/m9.figshare.26695860.v1figshare

Additional file 4 of SGLT2 inhibition, high-density lipoprotein, and kidney function: a mendelian randomization study

10.6084/m9.figshare.26695860figshare

Additional file 2 of SGLT2 inhibition, high-density lipoprotein, and kidney function: a mendelian randomization study

10.6084/m9.figshare.25449172figshare

Additional file 3 of SGLT2 inhibition, high-density lipoprotein, and kidney function: a mendelian randomization study

10.6084/m9.figshare.26695857figshare

Additional file 5 of SGLT2 inhibition, high-density lipoprotein, and kidney function: a mendelian randomization study

10.6084/m9.figshare.26695863figshare

Additional file 1 of SGLT2 inhibition, high-density lipoprotein, and kidney function: a mendelian randomization study

10.6084/m9.figshare.25449064.v1figshare

Additional file 1 of SGLT2 inhibition, high-density lipoprotein, and kidney function: a mendelian randomization study

10.6084/m9.figshare.25449064figshare

Calponin 2 harnesses metabolic reprogramming to determine kidney fibrosis

FAIR Checklist

Authors (15)

Funding (13 grants)

Impact

Open Access

Topics

Linked Datasets (10)

Annotations (Europe PMC)